U.S., Nov. 27 -- ClinicalTrials.gov registry received information related to the study (NCT07250152) titled 'Enhanced Prediction Model for Major Adverse Events Following Acute Myocardial Infarction' on Nov. 18.
Brief Summary: Acute myocardial infarction (AMI) remains a leading cause of mortality worldwide. Although early revascularization has markedly improved short-term outcomes, the incidence of major adverse cardiovascular events after the index event remains unacceptably high, posing a formidable clinical challenge. Contemporary risk-stratification instruments rely predominantly on a restricted set of conventional clinical variables and therefore fail to capture the full spectrum of individual pathophysiological complexity. To overcome...